Skip to main content
. 2024 Feb 8;3(2):166–185. doi: 10.1038/s44161-023-00418-4

Extended Data Fig. 1. HMB-001 analogue biAb0097 reduces blood loss after tail vein transection in transgenic haemophilia A mice expressing human TLT-1.

Extended Data Fig. 1

Mean blood loss as a function of (a) dose- and (b) plasma concentration of FVIIa following administration of FVIIa (n = 3–10, dark squares) or FVIIa coformulated with biAb0097 (1:1 mol/mol) (n = 6, red circles) in the tail vein transection model in HA mice carrying the human TLT-1 receptor. Data are mean blood loss ± s.d. FVIIa, activated factor VII; Hb, haemoglobin.

Source data